Member
Phare Bio
Phare Bio is a social venture dedicated to addressing the urgent global threat of antibiotic resistance through innovative AI and deep learning technologies. The company aims to revolutionize antibiotic discovery and development, ensuring that new antibiotics reach those in greatest need.
Industries
artificial-intelligence
biotechnology
Nr. of Employees
small (1-50)
Products
Generative AI antibiotics discovery platform
A platform that applies generative deep learning and interpretable ML to design, prioritize and accelerate novel antibiotic candidates.
Generative AI antibiotics discovery platform
A platform that applies generative deep learning and interpretable ML to design, prioritize and accelerate novel antibiotic candidates.
Expertise Areas
- AI-driven antibiotic discovery
- Generative deep learning model development
- High-throughput virtual screening
- Hit-to-lead optimization and ADME/Tox
Key Technologies
- Generative deep learning models
- Deep neural networks for activity prediction
- Explainable / interpretable machine learning
- Large-scale virtual screening
Key People
News & Updates
Phare Bio has received funding to enhance its AI-driven drug discovery efforts, focusing on developing new antibiotics.
Phare Bio is a recent recipient of the ARPA-H Award, aimed at accelerating AI-powered drug discovery.
Phare Bio has received funding to enhance its AI-driven drug discovery efforts, focusing on developing new antibiotics.
Phare Bio is a recent recipient of the ARPA-H Award, aimed at accelerating AI-powered drug discovery.